Skip to product information
1 of 1

Human Interleukin-3 Receptor Subunit Alpha (IL-3RA) ELISA Kit

Human Interleukin-3 Receptor Subunit Alpha (IL-3RA) ELISA Kit

This ELISA kit is designed to detect Human Interleukin-3 Receptor Subunit Alpha (Human IL-3RA). The assay plate has been pre-coated with mouse anti-Human IL-3R alpha monoclonal antibody. When the sample containing IL-3R alpha is added to the plate, it binds to the antibodies coated on the wells. Then, a horseradish peroxidase conjugated mouse anti-Human IL-3R alpha Antibody is added to the wells and binds to IL-3R alpha in the sample. After washing the wells, substrate solutions are added, and the color intensity is directly proportional to the amount of Human IL-3R alpha present. The reaction is stopped by adding an acidic stop solution, and the absorbance is measured at 450 nm.

Catalog No: BPE103
Regular price $624.00 USD
Regular price $480.00 USD Sale price $624.00 USD
Sale Sold out
Packaging
2 weeks
Download PDF

Product Details

Species Reactivity Human
Sensitivity 6.54 pg/mL
Detection Range 31.25-2000 pg/mL
Sample Type Serum, plasma, cell culture supernates
Incubation(s) 3.5 hour(s)
Research Areas Immunology, Signal Transduction
Background Interleukin-3 receptor subunit alpha, also known as IL-3 receptor subunit alpha, IL-3R-alpha, CD123, and IL3RA, is a single-pass type I membrane protein that belongs to the type I cytokine receptor family and Type 5 subfamily. The specific alpha subunit of the interleukin-3 receptor (IL-3Ralpha, CD123) is strongly expressed in various leukemic blasts and leukemic stem cells and seems to be an excellent target for the therapy of leukemias. The WSXWS motif of IL3RA appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding. The box one motif of IL3RA is required for JAK interaction and/or activation. IL3RA represents a unique marker for primitive leukemic stem cells. Targeting of IL3RA may be a promising strategy for the preferential ablation of AML cells. Aberrant IL3RA expression is a good marker for monitoring of minimal residual disease. IL3RA is strongly expressed in various leukemic blasts and leukemic stem cells and seems to be an excellent target for the therapy of leukemias. Recent studies have shown that interleukin-3 receptor alpha (CD123) is highly expressed on leukemia stem cells of patients with acute myeloid leukemia, and is correlated with tumor load and poor prognosis. CD123 was highly expressed in the bone marrow of the patients with myelodysplastic syndrome (MDS), significantly correlated with the proportion of bone marrow blasts, and thus might be the marker of MDS malignant clone. IL3RA is also a useful new marker for distinguishing B-cell disorders with circulating villous lymphocytes as its expression is characteristic of typical hairy cell leukemia (HCL) with high sensitivity and specificity.
Shipping Condition Shipped on cold gel packs.
Storage Condition and Shelf Life This product can be stored at 2-8C.
Analyte Interleukin-3 receptor subunit alpha
Regulatory Status For Research Use Only
View full details

Inquire about this product